Table 3.

Comparison of summary statistics of different covariates (patient characteristics, drug class, number of medications, use of combined medications, morbidity, and ABPM readings) among adherent and non-adherent (partially or fully non-adherent) groups (N = 235)

CovariateNon-adherent n (%)a (n= 61)Adherent n (%)a (n= 174)P-value
Age, mean (SD)69.9 (11.4)69.8 (10.4)0.956
Sex0.923
  Male35 (57.4)103 (59.2)
  Female26 (42.6)71 (40.8)
Diabetes0.982
  No42 (68.9)122 (70.1)
  Yes19 (31.1)52 (29.9)
Chronic kidney disease0.429
  Not CKD43 (70.5)111 (63.8)
  CKD18 (29.5)63 (36.2)
Angiotensin receptor blocker0.214
  No34 (55.7)79 (45.4)
  Yes27 (44.3)95 (54.6)
Beta-blocker0.297
  No27 (44.3)62 (35.6)
  Yes34 (55.7)112 (64.4)
ACE inhibitor0.095
  No29 (47.5)106 (60.9)
  Yes32 (52.5)68 (39.1)
Calcium channel blocker0.306
  No21 (34.4)46 (26.4)
  Yes40 (65.6)128 (73.6)
Diuretic0.460
  No1 (1.6)9 (5.2)
  Yes60 (98.4)165 (94.8)
3 medications1.000
  >3 medications34 (55.7)98 (56.3)
  3 medications only27 (44.3)76 (43.7)
Combination medications0.385
  No18 (29.5)64 (36.8)
  Yes43 (70.5)110 (63.2)
Documented CCF0.791
  Not documented54 (88.5)158 (90.8)
  Documented7 (11.5)16 (9.2)
Mean systolic day ABPM, mmHg (SD)137 (15.6)135 (16.0)0.435
Mean diastolic day ABPM, mmHg (SD)73.4 (11.2)73.1 (9.82)0.829
Mean systolic night ABPM, mmHg (SD)131 (19.7)129 (20.6)0.513
Mean diastolic night ABPM, mmHg (SD)67.8 (13.7)66.7 (11.9)0.609
ABPM total systolic, mmHg135 (16.5)133 (16.8)0.441
ABPM total diastolic, mmHg71.2 (11.5)70.5 (9.80)0.708
WCH0.136
  No51 (83.6)127 (73.0)
  Yes10 (16.4)47 (27.0)
  • a Number of participants and percentage, unless specified. ABPM = ambulatory blood pressure monitoring. CCF = congestive cardiac failure. WCH = white-coat hypertension.